nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—focal segmental glomerulosclerosis	0.784	1	CiPCiCtD
Boceprevir—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0278	0.49	CbGbCtD
Boceprevir—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.319	CbGbCtD
Boceprevir—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.191	CbGbCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—INF2—focal segmental glomerulosclerosis	0.00423	0.0503	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—MYO1E—focal segmental glomerulosclerosis	0.00423	0.0503	CbGpPWpGaD
Boceprevir—CTSV—nephron tubule—focal segmental glomerulosclerosis	0.00333	0.137	CbGeAlD
Boceprevir—CTSV—kidney—focal segmental glomerulosclerosis	0.00293	0.12	CbGeAlD
Boceprevir—CTSV—cortex of kidney—focal segmental glomerulosclerosis	0.00285	0.117	CbGeAlD
Boceprevir—CTSL—nephron tubule—focal segmental glomerulosclerosis	0.00272	0.112	CbGeAlD
Boceprevir—CTSL—kidney—focal segmental glomerulosclerosis	0.00239	0.0982	CbGeAlD
Boceprevir—CTSL—cortex of kidney—focal segmental glomerulosclerosis	0.00233	0.0956	CbGeAlD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00228	0.0271	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—PODXL—focal segmental glomerulosclerosis	0.00207	0.0246	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—PTPRO—focal segmental glomerulosclerosis	0.00207	0.0246	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—NPHS2—focal segmental glomerulosclerosis	0.00207	0.0246	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ACE—focal segmental glomerulosclerosis	0.00204	0.0243	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00195	0.0232	CbGpPWpGaD
Boceprevir—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.0369	CcSEcCtD
Boceprevir—CTSK—kidney—focal segmental glomerulosclerosis	0.0018	0.074	CbGeAlD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—COL4A4—focal segmental glomerulosclerosis	0.00177	0.021	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—COL4A4—focal segmental glomerulosclerosis	0.00177	0.021	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00176	0.0209	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—CD2AP—focal segmental glomerulosclerosis	0.00169	0.02	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—COL4A1—focal segmental glomerulosclerosis	0.00162	0.0193	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—COL4A1—focal segmental glomerulosclerosis	0.00162	0.0193	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—ACTN4—focal segmental glomerulosclerosis	0.00162	0.0193	CbGpPWpGaD
Boceprevir—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0319	CcSEcCtD
Boceprevir—CTSS—kidney—focal segmental glomerulosclerosis	0.00158	0.0648	CbGeAlD
Boceprevir—CTSS—cortex of kidney—focal segmental glomerulosclerosis	0.00154	0.0631	CbGeAlD
Boceprevir—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0303	CcSEcCtD
Boceprevir—Telaprevir—ALB—focal segmental glomerulosclerosis	0.00147	1	CrCbGaD
Boceprevir—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0296	CcSEcCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—NPHS1—focal segmental glomerulosclerosis	0.0014	0.0166	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—COL4A3—focal segmental glomerulosclerosis	0.00137	0.0163	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—COL4A3—focal segmental glomerulosclerosis	0.00137	0.0163	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—COL4A4—focal segmental glomerulosclerosis	0.00136	0.0162	CbGpPWpGaD
Boceprevir—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.027	CcSEcCtD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—AGT—focal segmental glomerulosclerosis	0.0013	0.0154	CbGpPWpGaD
Boceprevir—CTSK—Osteoclast Signaling—SPP1—focal segmental glomerulosclerosis	0.00128	0.0152	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00124	0.0147	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A4—focal segmental glomerulosclerosis	0.00121	0.0143	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—COL4A4—focal segmental glomerulosclerosis	0.0012	0.0143	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—COL4A4—focal segmental glomerulosclerosis	0.0012	0.0143	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A1—focal segmental glomerulosclerosis	0.00111	0.0132	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—COL4A1—focal segmental glomerulosclerosis	0.00111	0.0132	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—COL4A1—focal segmental glomerulosclerosis	0.00111	0.0132	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—COL4A3—focal segmental glomerulosclerosis	0.00106	0.0126	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—MYH9—focal segmental glomerulosclerosis	0.00101	0.012	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A3—focal segmental glomerulosclerosis	0.000937	0.0111	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—COL4A3—focal segmental glomerulosclerosis	0.000935	0.0111	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—COL4A3—focal segmental glomerulosclerosis	0.000935	0.0111	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—WT1—focal segmental glomerulosclerosis	0.0009	0.0107	CbGpPWpGaD
Boceprevir—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.000885	0.0179	CcSEcCtD
Boceprevir—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.000842	0.017	CcSEcCtD
Boceprevir—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.0168	CcSEcCtD
Boceprevir—CTSS—Collagen formation—COL4A4—focal segmental glomerulosclerosis	0.000822	0.00977	CbGpPWpGaD
Boceprevir—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.0158	CcSEcCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TRPC6—focal segmental glomerulosclerosis	0.000778	0.00925	CbGpPWpGaD
Boceprevir—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.0157	CcSEcCtD
Boceprevir—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.0153	CcSEcCtD
Boceprevir—CTSS—Collagen formation—COL4A1—focal segmental glomerulosclerosis	0.000755	0.00898	CbGpPWpGaD
Boceprevir—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.015	CcSEcCtD
Boceprevir—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.0149	CcSEcCtD
Boceprevir—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.0147	CcSEcCtD
Boceprevir—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.0144	CcSEcCtD
Boceprevir—CTSS—Collagen formation—COL4A3—focal segmental glomerulosclerosis	0.000638	0.00759	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.000628	0.00746	CbGpPWpGaD
Boceprevir—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.0124	CcSEcCtD
Boceprevir—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.0123	CcSEcCtD
Boceprevir—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.0123	CcSEcCtD
Boceprevir—CMA1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000599	0.00713	CbGpPWpGaD
Boceprevir—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000597	0.0245	CbGeAlD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.000583	0.00693	CbGpPWpGaD
Boceprevir—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.000552	0.0111	CcSEcCtD
Boceprevir—CTSL—Collagen degradation—MMP2—focal segmental glomerulosclerosis	0.000547	0.0065	CbGpPWpGaD
Boceprevir—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.011	CcSEcCtD
Boceprevir—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.011	CcSEcCtD
Boceprevir—CMA1—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.000538	0.00639	CbGpPWpGaD
Boceprevir—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000529	0.0107	CcSEcCtD
Boceprevir—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.000525	0.0106	CcSEcCtD
Boceprevir—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000525	0.0106	CcSEcCtD
Boceprevir—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000524	0.0215	CbGeAlD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.00052	0.00618	CbGpPWpGaD
Boceprevir—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.0105	CcSEcCtD
Boceprevir—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.0105	CcSEcCtD
Boceprevir—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.0105	CcSEcCtD
Boceprevir—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.0104	CcSEcCtD
Boceprevir—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.0104	CcSEcCtD
Boceprevir—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.0103	CcSEcCtD
Boceprevir—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000511	0.021	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—SPP1—focal segmental glomerulosclerosis	0.000509	0.00605	CbGpPWpGaD
Boceprevir—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.0101	CcSEcCtD
Boceprevir—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.00981	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000482	0.00573	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000482	0.00573	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.000472	0.00561	CbGpPWpGaD
Boceprevir—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.00936	CcSEcCtD
Boceprevir—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.0092	CcSEcCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—PCNA—focal segmental glomerulosclerosis	0.000455	0.00541	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP2—focal segmental glomerulosclerosis	0.000453	0.00539	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000448	0.00533	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000443	0.00526	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000443	0.00526	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.000439	0.00521	CbGpPWpGaD
Boceprevir—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.000432	0.00871	CcSEcCtD
Boceprevir—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00836	CcSEcCtD
Boceprevir—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00836	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000412	0.00489	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP9—focal segmental glomerulosclerosis	0.000411	0.00489	CbGpPWpGaD
Boceprevir—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000407	0.0082	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000399	0.00475	CbGpPWpGaD
Boceprevir—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00804	CcSEcCtD
Boceprevir—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000393	0.0162	CbGeAlD
Boceprevir—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.00789	CcSEcCtD
Boceprevir—CTSV—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000391	0.00465	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000391	0.00465	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.000391	0.00465	CbGpPWpGaD
Boceprevir—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.00782	CcSEcCtD
Boceprevir—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00778	CcSEcCtD
Boceprevir—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.00775	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000374	0.00445	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000374	0.00445	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000367	0.00436	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000364	0.00432	CbGpPWpGaD
Boceprevir—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.0072	CcSEcCtD
Boceprevir—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.00714	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000348	0.00413	CbGpPWpGaD
Boceprevir—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00688	CcSEcCtD
Boceprevir—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00688	CcSEcCtD
Boceprevir—CMA1—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000341	0.00405	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP9—focal segmental glomerulosclerosis	0.000341	0.00405	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000329	0.00391	CbGpPWpGaD
Boceprevir—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.00663	CcSEcCtD
Boceprevir—CTSK—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000324	0.00385	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP9—focal segmental glomerulosclerosis	0.00032	0.0038	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP9—focal segmental glomerulosclerosis	0.00032	0.0038	CbGpPWpGaD
Boceprevir—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00641	CcSEcCtD
Boceprevir—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000317	0.013	CbGeAlD
Boceprevir—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.00639	CcSEcCtD
Boceprevir—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000313	0.00632	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.00031	0.00369	CbGpPWpGaD
Boceprevir—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00619	CcSEcCtD
Boceprevir—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.00617	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000302	0.00359	CbGpPWpGaD
Boceprevir—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.00609	CcSEcCtD
Boceprevir—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.00605	CcSEcCtD
Boceprevir—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.00593	CcSEcCtD
Boceprevir—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.00581	CcSEcCtD
Boceprevir—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.0058	CcSEcCtD
Boceprevir—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00028	0.00565	CcSEcCtD
Boceprevir—ABCB1—kidney—focal segmental glomerulosclerosis	0.000278	0.0114	CbGeAlD
Boceprevir—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00558	CcSEcCtD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000277	0.00329	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000277	0.00329	CbGpPWpGaD
Boceprevir—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00547	CcSEcCtD
Boceprevir—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000271	0.0111	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—MMP9—focal segmental glomerulosclerosis	0.000271	0.00322	CbGpPWpGaD
Boceprevir—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00027	0.00545	CcSEcCtD
Boceprevir—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.00542	CcSEcCtD
Boceprevir—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00539	CcSEcCtD
Boceprevir—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00539	CcSEcCtD
Boceprevir—CTSS—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000267	0.00317	CbGpPWpGaD
Boceprevir—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00537	CcSEcCtD
Boceprevir—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00528	CcSEcCtD
Boceprevir—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.00525	CcSEcCtD
Boceprevir—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00524	CcSEcCtD
Boceprevir—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00524	CcSEcCtD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000257	0.00306	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000255	0.00303	CbGpPWpGaD
Boceprevir—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.0051	CcSEcCtD
Boceprevir—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00508	CcSEcCtD
Boceprevir—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00506	CcSEcCtD
Boceprevir—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000241	0.00485	CcSEcCtD
Boceprevir—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.00481	CcSEcCtD
Boceprevir—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.0048	CcSEcCtD
Boceprevir—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.00478	CcSEcCtD
Boceprevir—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00475	CcSEcCtD
Boceprevir—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00474	CcSEcCtD
Boceprevir—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.00466	CcSEcCtD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000229	0.00273	CbGpPWpGaD
Boceprevir—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000224	0.00451	CcSEcCtD
Boceprevir—CTSV—Endochondral Ossification—TGFB1—focal segmental glomerulosclerosis	0.000223	0.00265	CbGpPWpGaD
Boceprevir—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00449	CcSEcCtD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—focal segmental glomerulosclerosis	0.000218	0.00259	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP9—focal segmental glomerulosclerosis	0.000218	0.00259	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP9—focal segmental glomerulosclerosis	0.000218	0.00259	CbGpPWpGaD
Boceprevir—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00439	CcSEcCtD
Boceprevir—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00436	CcSEcCtD
Boceprevir—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00434	CcSEcCtD
Boceprevir—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.00432	CcSEcCtD
Boceprevir—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00428	CcSEcCtD
Boceprevir—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00424	CcSEcCtD
Boceprevir—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00421	CcSEcCtD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000208	0.00247	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000208	0.00247	CbGpPWpGaD
Boceprevir—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00415	CcSEcCtD
Boceprevir—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.00412	CcSEcCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—focal segmental glomerulosclerosis	0.000203	0.00242	CbGpPWpGaD
Boceprevir—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00405	CcSEcCtD
Boceprevir—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000197	0.00397	CcSEcCtD
Boceprevir—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00391	CcSEcCtD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000193	0.0023	CbGpPWpGaD
Boceprevir—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00389	CcSEcCtD
Boceprevir—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00387	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000191	0.00227	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000191	0.00227	CbGpPWpGaD
Boceprevir—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00385	CcSEcCtD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000189	0.00225	CbGpPWpGaD
Boceprevir—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.0038	CcSEcCtD
Boceprevir—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.00378	CcSEcCtD
Boceprevir—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00377	CcSEcCtD
Boceprevir—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00368	CcSEcCtD
Boceprevir—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00364	CcSEcCtD
Boceprevir—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00359	CcSEcCtD
Boceprevir—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00359	CcSEcCtD
Boceprevir—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00359	CcSEcCtD
Boceprevir—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00357	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00356	CcSEcCtD
Boceprevir—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00354	CcSEcCtD
Boceprevir—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00351	CcSEcCtD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000172	0.00205	CbGpPWpGaD
Boceprevir—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000172	0.00347	CcSEcCtD
Boceprevir—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00342	CcSEcCtD
Boceprevir—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00337	CcSEcCtD
Boceprevir—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00337	CcSEcCtD
Boceprevir—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00334	CcSEcCtD
Boceprevir—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00332	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000164	0.00195	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000164	0.00195	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000158	0.00188	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.00313	CcSEcCtD
Boceprevir—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000154	0.00311	CcSEcCtD
Boceprevir—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00309	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000152	0.00181	CbGpPWpGaD
Boceprevir—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00306	CcSEcCtD
Boceprevir—CTSV—Immune System—PIAS1—focal segmental glomerulosclerosis	0.00015	0.00178	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIAS1—focal segmental glomerulosclerosis	0.00015	0.00178	CbGpPWpGaD
Boceprevir—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00303	CcSEcCtD
Boceprevir—CTSS—Collagen formation—MMP9—focal segmental glomerulosclerosis	0.000149	0.00177	CbGpPWpGaD
Boceprevir—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00299	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00297	CcSEcCtD
Boceprevir—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00296	CcSEcCtD
Boceprevir—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00294	CcSEcCtD
Boceprevir—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00294	CcSEcCtD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000142	0.00169	CbGpPWpGaD
Boceprevir—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00283	CcSEcCtD
Boceprevir—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00281	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000137	0.00163	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000137	0.00163	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000136	0.00161	CbGpPWpGaD
Boceprevir—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00273	CcSEcCtD
Boceprevir—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00272	CcSEcCtD
Boceprevir—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00272	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000134	0.00159	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.00013	0.00155	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000127	0.00151	CbGpPWpGaD
Boceprevir—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.00253	CcSEcCtD
Boceprevir—CTSK—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000124	0.00148	CbGpPWpGaD
Boceprevir—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000122	0.00247	CcSEcCtD
Boceprevir—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.00243	CcSEcCtD
Boceprevir—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.00235	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000116	0.00138	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000116	0.00138	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000114	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000114	0.00135	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000113	0.00135	CbGpPWpGaD
Boceprevir—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000113	0.00227	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000112	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MYH9—focal segmental glomerulosclerosis	0.000111	0.00132	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MYH9—focal segmental glomerulosclerosis	0.000111	0.00132	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000111	0.00132	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000111	0.00132	CbGpPWpGaD
Boceprevir—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000108	0.00219	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000108	0.00128	CbGpPWpGaD
Boceprevir—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00217	CcSEcCtD
Boceprevir—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00217	CcSEcCtD
Boceprevir—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00215	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.00126	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000102	0.00122	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000101	0.00121	CbGpPWpGaD
Boceprevir—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.00204	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	9.61e-05	0.00114	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	9.43e-05	0.00112	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	9.34e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MYH9—focal segmental glomerulosclerosis	9.22e-05	0.0011	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	9.21e-05	0.00109	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	9.06e-05	0.00108	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	9.06e-05	0.00108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.03e-05	0.00107	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	8.72e-05	0.00104	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	8.72e-05	0.00104	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.29e-05	0.000986	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	8.11e-05	0.000963	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	7.92e-05	0.000941	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	7.77e-05	0.000923	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MYH9—focal segmental glomerulosclerosis	7.59e-05	0.000902	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	7.58e-05	0.000901	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	7.51e-05	0.000892	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	7.23e-05	0.000859	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	7.19e-05	0.000854	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	7.19e-05	0.000854	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	7.02e-05	0.000835	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.01e-05	0.000833	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—focal segmental glomerulosclerosis	6.74e-05	0.000801	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—focal segmental glomerulosclerosis	6.74e-05	0.000801	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	6.68e-05	0.000794	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	6.43e-05	0.000765	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	6.21e-05	0.000738	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	6.18e-05	0.000735	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	6.08e-05	0.000723	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	5.95e-05	0.000708	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	5.95e-05	0.000707	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—focal segmental glomerulosclerosis	5.58e-05	0.000664	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD40LG—focal segmental glomerulosclerosis	5.49e-05	0.000653	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD40LG—focal segmental glomerulosclerosis	5.49e-05	0.000653	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	5.21e-05	0.000619	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.15e-05	0.000613	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.12e-05	0.000609	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	5.04e-05	0.000599	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	4.9e-05	0.000583	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.64e-05	0.000551	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.61e-05	0.000548	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD79A—focal segmental glomerulosclerosis	4.6e-05	0.000547	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD40LG—focal segmental glomerulosclerosis	4.55e-05	0.000541	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.31e-05	0.000512	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.94e-05	0.000468	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.88e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD40LG—focal segmental glomerulosclerosis	3.75e-05	0.000446	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.34e-05	0.000397	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.24e-05	0.000385	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.07e-05	0.000365	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.77e-05	0.00033	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.56e-05	0.000305	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.34e-05	0.000279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.13e-05	0.000253	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.12e-05	0.000252	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.63e-05	0.000194	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.59e-05	0.000189	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.35e-05	0.00016	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.05e-05	0.000124	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	1.02e-05	0.000121	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	8.97e-06	0.000107	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.26e-06	9.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.68e-06	9.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.77e-06	8.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.57e-06	7.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.23e-06	7.41e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	6.21e-06	7.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	5.32e-06	6.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.73e-06	5.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.69e-06	5.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.17e-06	4.95e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	4.08e-06	4.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.01e-06	4.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.84e-06	4.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.08e-06	3.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.89e-06	3.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.47e-06	2.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.9e-06	2.25e-05	CbGpPWpGaD
